Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
CQt0LH4ewDE4bUyD
